Transient overexpression of KRAS, transcript variant a, in HEK293T cells, FFPE control for IHC, ICC and ISH staining, 25 slides per pack
Products
Transient overexpression of KRAS, transcript variant b, in HEK293T cells, FFPE control for IHC, ICC and ISH staining, 25 slides per pack
Kras - Mouse, 4 unique 29mer shRNA constructs in lentiviral GFP vector, 5µg of each construct provided
| Format | Lentiviral plasmids |
| Vector | pGFP-C-shLenti |
Kras - Rat, 4 unique 29mer shRNA constructs in lentiviral GFP vector, 5µg of each construct provided
| Format | Lentiviral plasmids |
| Vector | pGFP-C-shLenti |
Kras - Rat, 4 unique 29mer shRNA constructs in retroviral untagged vector, 5µg of each construct provided
| Format | Retroviral plasmids |
| Vector | pRS |
KRAS Rabbit polyclonal Antibody
| Applications | ELISA, ICC/IF, WB |
| Reactivities | Human, Mouse, Rat |
| Modifications | Unmodified |
热销推荐
KRAS mutant (G12V), Myc-DDK-tagged ORF clone of Homo sapiens v-Ki-ras2 Kirsten rat sarcoma viral oncogene homolog (KRAS), transcript variant b as transfection-ready DNA
| Mutation | G12V |
| Tag | Myc-DDK |
| Vector | pCMV6-Entry |
- TrueORF®
KRAS mutant (G13D), Myc-DDK-tagged ORF clone of Homo sapiens v-Ki-ras2 Kirsten rat sarcoma viral oncogene homolog (KRAS), transcript variant b as transfection-ready DNA
| Mutation | G13D |
| Tag | Myc-DDK |
| Vector | pCMV6-Entry |
- TrueORF®
活动过滤器
优化搜索结果
Species
Reactivities
Antibody Hosts
Expression Hosts
Lentivirus
Vectors
- pCMV6-Entry (26)
- pLenti-C-Myc-DDK-P2A-Puro (4)
- pLenti-C-mGFP-P2A-Puro (4)
- pCMV6-AC-GFP (3)
- pGFP-C-shLenti (3)
- pLenti-C-Myc-DDK (3)
- pLenti-C-mGFP (3)
- pRS (3)
- EF1a-GFP-P2A-Puro (2)
- GFP-puro (2)
- Luciferase-Puro (2)
- RFP-BSD (2)
- mBFP-Neo (2)
- pRFP-C-RS (2)
- PCMV6-Kan/Neo (1)
- pCMV6-XL4 (1)
- pCMV6-XL6 (1)
- pGFP-V-RS (1)
Reporters
Knockout (KO) Validation
Conjugates
Modifications
Isotypes
Clonalities
Assay Types
Brands
QC Levels
Families
Pathways
- Acute myeloid leukemia (98)
- Axon guidance (98)
- B cell receptor signaling pathway (98)
- Bladder cancer (98)
- Chemokine signaling pathway (98)
- Chronic myeloid leukemia (98)
- Colorectal cancer (98)
- Dorso-ventral axis formation (98)
- Endometrial cancer (98)
- ErbB signaling pathway (98)
- Fc epsilon RI signaling pathway (98)
- Gap junction (98)
- Glioma (98)
- GnRH signaling pathway (98)
- Insulin signaling pathway (98)
- Long-term depression (98)
- Long-term potentiation (98)
- MAPK signaling pathway (98)
- Melanogenesis (98)
- Melanoma (98)
- Natural killer cell mediated cytotoxicity (98)
- Neurotrophin signaling pathway (98)
- Non-small cell lung cancer (98)
- Pancreatic cancer (98)
- Pathways in cancer (98)
- Progesterone-mediated oocyte maturation (98)
- Prostate cancer (98)
- Regulation of actin cytoskeleton (98)
- Renal cell carcinoma (98)
- T cell receptor signaling pathway (98)
- Thyroid cancer (98)
- Tight junction (98)
- VEGF signaling pathway (98)
